Innocoll's Unattributed - IV Round

Innocoll raised a round of funding on August 12, 2011. Investors include NewSmith Asset Management.

Innocoll is a global commercial stage specialty pharmaceutical company with late stage development programs targeting areas of significant unmet medical need. The company develops and manufactures a r…

Articles about Innocoll's Unattributed - IV Round: